Should you continue to hold Smithson Investment Trust?
Smithson Investment Trust, a small- and mid-cap fund, has struggled to live up to lofty expectations, says Rupert Hargreaves.


The initial public offering of Smithson Investment Trust (LSE: SSON) was one of the biggest launches the investment trust sector has ever seen. Backed by Terry Smith, the manager of the £22.5 billion Fundsmith Equity Fund, Smithson had no trouble raising £822 million from investors who queued up to back its small- and mid-cap investment strategy. Its assets under management have since expanded to £2.3 billion.
Smithson pursues a version of Fundsmith Equity’s quality and growth investment strategy, targeting companies that might not fit into the larger fund. The trust’s own website proclaims, “We aim to provide you with a similar investment experience to the Fundsmith Equity Fund, being a superior risk-adjusted return over the long term, but by investing in a group of global small- and mid-capitalisation listed companies.”
Unfortunately, the trust has struggled since its inception. Net asset value (NAV) has grown 8.2% annually since 2018, compared with 8.3% for the MSCI World SMID index. Thanks to the widening discount, the stock price has returned just 6.6%, lagging the index by 1.7% per annum. Last year the gap widened further. The trust returned 2.1% on a NAV basis, compared with a 11.5% gain for its benchmark.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
As the discount to net asset value has widened, the trust has devoted more cash to share buybacks. In fact, since 2022, Smithson has spent more cash buying back its own shares than anything else. It has repurchased £500 million of stock over the past few years, or £10 million a week (by comparison, its largest position, Diploma, is about £115 million). Despite this outlay, it still trades at a double-digit discount.
A shift in strategy for Smithson Investment Trust
In an attempt to revitalise performance, manager Simon Barnard has recently redefined the trust’s strategy to focus on the smaller end of the £500 million - £15 billion market-cap range the company has focused on in the past. Here there’s more scope to find the multi-bagger companies of the future, the team believes.
This could be too little, too late. Despite the trust’s aggressive buybacks, Smithson’s wide discount to net asset value is a worrying sign. Investors are not lining up to buy the shares as they once were. Moreover, Smithson’s underperformance has attracted the attention of Saba Capital, the New York hedge fund that’s been agitating for change across the investment trust sector. Recently, Saba Capital Income and Opportunities Fund II filings revealed it had bought total return swaps, giving it an economic interest of £7.4 million in Smithson as of 31 October. It’s not clear if Saba still owns a stake, but based on its past actions, Smithson is ripe for Saba’s style of activism.
Smithson may have to hold another continuation vote
Saba isn’t the only threat to Smithson’s longevity. Terry Smith, who is one of Smithson’s largest investors as well as the majority owner of Fundsmith, has acted in the past to close a trust carrying his name that has not lived up to expectations. He closed the Fundsmith Emerging Equities Trust in 2022 after its discount widened to 14.9%.
This year the trust will be required to hold another continuation vote if the discount exceeds 10%. It already had to do the same in 2024, although the board caused an almighty row when it initially decided against holding a vote, even though the double-digit discount required it. Overall, 9.6% of votes were cast against continuation last time. The votes in favour were more than enough to prevent a winding up, but that number can’t be taken for granted.
Smithson was launched with a clear brief in mind, but despite Fundsmith’s record, the managers have not been able to replicate the success of Smith’s large-cap focused Fundsmith Equity Fund. The trust’s hefty fees (0.9%), underperformance and persistent discount suggest its future is limited. Investors may be better off seeking small-cap growth elsewhere.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

Rupert is the former deputy digital editor of MoneyWeek. He's an active investor and has always been fascinated by the world of business and investing. His style has been heavily influenced by US investors Warren Buffett and Philip Carret. He is always looking for high-quality growth opportunities trading at a reasonable price, preferring cash generative businesses with strong balance sheets over blue-sky growth stocks.
Rupert has written for many UK and international publications including the Motley Fool, Gurufocus and ValueWalk, aimed at a range of readers; from the first timers to experienced high-net-worth individuals. Rupert has also founded and managed several businesses, including the New York-based hedge fund newsletter, Hidden Value Stocks. He has written over 20 ebooks and appeared as an expert commentator on the BBC World Service.
-
Is it time to ride the recovery in emerging markets?
Interview What's the outlook for emerging markets? Gustavo Medeiros, head of research at Ashmore Group, gives his analysis and reviews progress in developing economies
-
Could the Enterprise Investment Scheme cut your tax bill?
The Enterprise Investment Scheme is tax-efficient and potentially lucrative. Taking a chance on the scheme could trim your family’s IHT bill, says David Prosser
-
'Ride the recovery in emerging markets': Gustavo Medeiros of Ashmore Group tells MoneyWeek
Interview What's the outlook for emerging markets? Gustavo Medeiros, head of research at Ashmore Group, gives his analysis and reviews progress in developing economies
-
What is the Enterprise Investment Scheme and should you have one?
The Enterprise Investment Scheme is tax-efficient and potentially lucrative. Taking a chance on the scheme could trim your family’s IHT bill, says David Prosser
-
The alcohol industry is suffering as consumers sober up – is it still worth investing in the sector?
Changing consumer tastes are rocking the alcohol industry, but the best players are adapting their strategies. Buy them while their shares are still cheap
-
A strange calm in credit
Corporate bond markets remain remarkably relaxed, with yields that offer little compensation for risks
-
The City's big bet on green finance fails to pay out
Opinion Insurers and banks are backing away from “green finance”, and there is not much sign of the green boom we were promised. That’s a problem for the City
-
Why is English football thriving – and can it last?
What has gone so right for English football? The national team has found its feet; the Premier League is swimming in money and profits are soaring
-
Six top investment trusts for smaller stocks
Liquidity constraints mean investment trusts are best placed to seize the juiciest opportunities
-
Could colour diamonds add a sparkle to your portfolio?
Diamonds of various shades never go out of fashion, says Chris Carter